CITIUS ONCOLOGY, INC.
CTORNasdaq
$0.69
↑ +1.0%Jul 17 close · end-of-day
Price
1Y↓ -56.1%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$68.9M
Enterprise Value
$66.3M
P/E
—
P/S
—
P/B
2.0
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$42.5M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-120.5%
ROIC
-105.4%
Debt / Equity
—
Net Cash
$2.6M
Return 1Y
-56.9%
Company profile
Management & directors
- Bartushak JaimeChief Financial Officer
- Czuczman MyronChief Medical Officer
- Holubiak Myron ZSecretary
- Mazur Leonard LChief Executive Officer
Roles derived from SEC Form 4 filings.
Earnings
CTOR Q2 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$1.7M—
Diluted EPS-$0.27↑ +145.5%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$138,115.00 | — | -$1.0M | -$20.6M | -$23.5M |
| Net income | $380,811.00 | -$12.7M | $2.4M | -$21.1M | -$24.8M |
| Diluted EPS | $0.12 | -$0.19 | $0.27 | -$0.31 | -$0.34 |
| Operating cash flow | -$47,968.00 | — | -$601,304.00 | $126,353.00 | -$5.5M |
| Free cash flow | — | — | — | — | — |
| Gross margin | — | — | — | — | — |
| Operating margin | — | — | — | — | — |
| Net margin | — | — | — | — | — |
| Line item | Q3 '24 | Q4 '24 | Q1 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $3.9M | $1.7M |
| Gross profit | — | — | — | — | — | — | $3.2M | $1.3M |
| Operating income | -$4.6M | — | -$6.4M | -$7.5M | -$4.9M | -$4.7M | -$5.3M | -$28.6M |
| Net income | -$4.8M | -$6.8M | -$6.7M | -$7.7M | -$5.4M | -$5.0M | -$5.5M | -$26.6M |
| Diluted EPS | -$0.07 | -$0.10 | -$0.09 | -$0.11 | -$0.08 | -$0.06 | -$0.06 | -$0.27 |
| Operating cash flow | -$366,106.00 | — | — | — | — | — | -$7.4M | -$3.8M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | 80.0% | 80.3% |
| Operating margin | — | — | — | — | — | — | -133.2% | -1716.2% |
| Net margin | — | — | — | — | — | — | -140.3% | -1596.0% |
Company news
Coming soonHeadlines for CTOR will appear here once the news feed is connected.
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2025-09-19 | Webb Carol | Award | 300,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | HOLUBIAK MYRON Z· Secretary | Award | 850,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | Czuczman Myron· Chief Medical Officer | Award | 825,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | Bartushak Jaime· Chief Financial Officer | Award | 825,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | Mazur Leonard L· Chief Executive Officer | Award | 1,700,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | Smith Robert Joseph | Award | 300,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | MCGRATH DENNIS M | Award | 300,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | Mayersohn Joel David | Award | 300,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | Dutia Suren G | Award | 300,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | Holuka Eugene Myron | Award | 300,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | Holuka Eugene Myron | Award | 300,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | Mayersohn Joel David | Award | 300,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | Webb Carol | Award | 300,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | MCGRATH DENNIS M | Award | 300,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | Bartushak Jaime· Chief Financial Officer | Award | 825,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | HOLUBIAK MYRON Z· Secretary | Award | 850,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | Smith Robert Joseph | Award | 300,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | Dutia Suren G | Award | 300,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | Mazur Leonard L· Chief Executive Officer | Award | 1,700,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | Czuczman Myron· Chief Medical Officer | Award | 825,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | HOLUBIAK MYRON Z· Secretary | Award | 850,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | HOLUBIAK MYRON Z· Secretary | Award | 100,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | Smith Robert Joseph | Award | 300,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | Mazur Leonard L· Chief Executive Officer | Award | 1,700,000 | $0.00 | $0.00 | filing |
| 2025-09-19 | Webb Carol | Award | 300,000 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.